#13184-2 – Men and Women with Severe Liver Disease

Location: Denver

Stay: 6 nights/7 days, plus 1 follow-up phone call

Gender: Male/Female

Ages: 18-75

Compensation: $1550

Smokers Allowed: No

Study Overview:

This study will examine how the body processes the study drug MEK162, along with its' safety and tolerability. We will compare how this occurs in individuals with serious liver disease, as compared to individuals with normal liver function. This study drug has the potential to benefit patients with advanced cancers.

Enroll In This Study